Skip to main content

Advertisement

Table 1 Cell-cycle phase distribution (%) of 72 h HS7-treated CL1-0 cells

From: Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells

Treatment Sub-G1 (%)a Cell-cycle distribution
G0/G1 (%) S (%) G2/M (%)
Control 1.42 69.8 14.6 15.6
HS7 3.125 μg/mL 1.33 65.9 13.2 20.9
HS7 6.25 μg/mL 1.63 68.3 13.6 18.1
HS7 12.5 μg/mL 1.73 68 14.4 17.6
HS7 25 μg/mL 10.06 63.1 18.6 18.3
  1. aSub-G1 proportion is excluded from the percentage calculation of cell-cycle distribution